Unicycive Therapeutics (UNCY)

Results From Phase 1 Trial Testing UNI-494 In Acute Kidney Injury Announced


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
October 10, 2024
Report ID: 27025
Already Registered?
Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc.
Healthcare
Biotechnology
Ticker
UNCY
Current Price
$0.59 3.55%
Market Cap
$55.7M
Price Target
Refer to Report
Volume
2.3M
52wk Range
$0.202 - $1.818
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.